Amedisys, Inc. (AMED) has a consensus analyst rating of Hold, based on 28 analysts covering the stock. Of those, 8 recommend buying, 18 recommend holding, and 2 recommend selling.
The analyst consensus price target for AMED is $143.38, representing a +42.0% upside from the current price of $100.99. Price targets range from a low of $85.00 to a high of $190.00.
